Wellington Management Group’s Pacific Biosciences PACB Stock Holding History

Wellington Management Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-227,661	Closed	-$1.17M	–	2010
2019 Q4	$1.17M	Buy	227,661 +91,042	+67%	+$463K	﹤0.01%	1670
2019 Q3	$706K	Sell	136,619 -103,225	-43%	-$577K	﹤0.01%	1799
2019 Q2	$1.45M	Sell	239,844 -193,621	-45%	-$1.36M	﹤0.01%	1693
2019 Q1	$3.13M	Sell	433,465 -33,347	-7%	-$241K	﹤0.01%	1498
2018 Q4	$3.46M	Buy	+466,812	New	+$2.96M	﹤0.01%	1482
2014 Q4	–	Sell	-119,713	Closed	-$587K	–	2221
2014 Q3	$587K	Buy	119,713 +55,530	+87%	+$290K	﹤0.01%	1949
2014 Q2	$396K	Hold	64,183	–	–	﹤0.01%	2027
2014 Q1	$343K	Buy	+64,183	New	+$406K	﹤0.01%	2046

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

KLCMU

Kite Lake Capital Management (UK) London, United Kingdom $290M AUM 183.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group's PACB Position: Q1 2020 in Review

Wellington Management Group sold out of Pacific Biosciences (PACB) in Q1 2020, closing a stake of 227,661 shares — an estimated $1.17M sold.

Wellington Management Group first reported a position in PACB in Q1 2014 and held it in 8 quarters. The position peaked at $3.46M in Q4 2018. 132 funds tracked by Wall St. Rank hold PACB as of Q1 2020.

Wellington Management Group reported no remaining Pacific Biosciences position as of Q1 2020 after selling out during the quarter.
Wellington Management Group sold 227,661 Pacific Biosciences shares in Q1 2020, an estimated $1.17M.
Wellington Management Group first reported a position in Pacific Biosciences in Q1 2014 and held it in 8 quarters.
Wellington Management Group's Pacific Biosciences position peaked at $3.46M in Q4 2018.
132 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.